Instructions
for Authors
(Submission Guidelines/Formats)
First
issued date February
10, 2022
Revision as of October 6, 2023
Revision as of May 3, 2024
Revision as of December 20, 2024
Revision as of April 20, 2025
1. Manuscript Types and Specifications
The Archives of Obesity and Metabolism
(AOM) is a peer-reviewed journal published twice per year on June 30 and December
31. This journal covers articles on obesity, metabolic syndrome, and
complications of obesity. Manuscripts may include reviews, original research,
case reports, perspectives, editorials, and correspondences.
The submission
guidelines for the AOM are based on the "Recommendations for the Conduct,
Reporting, Editing, and Publication of Scholarly Work in Medical Journals"
by the International Committee of Medical Journal Editors (ICMJE) (http://www.icmje.org/icmje-recommendations.pdf).
Authors must specify
the manuscript type on the cover page of their submission.
1) Review: A
manuscript presenting insights and perspectives on topics related to obesity,
metabolic syndrome, and complications of obesity through a review of existing
research. Submissions can be made by the author, or the Editorial Board may
request specific topics and contributors.
2) Original Article: A
manuscript presenting research findings derived from various studies related to
obesity, metabolic syndrome, and complications of obesity.
3) Case Report: A
manuscript reporting new or previously unobserved phenomena, as well as clinical
cases that are relevant to the scope of the journal and have educational value.
4) Perspective: A
manuscript presenting the author’s knowledge and viewpoint on existing or
emerging academic issues. Submissions can be made by the author, or the
Editorial Board may request specific topics and contributors.
5) Editorial: A
manuscript providing commentary and analysis on recently published papers in the
AOM. These articles are written by the Editorial Board or authors commissioned
by the Editorial Board.
6) Correspondence: A
manuscript commenting on recent papers published in the AOM, new cases, or
other topics of interest within the scope of the journal.
The final decision on
manuscript acceptance is made following the review by the Editorial Board if
deemed significant.
2. Preparation
of Submitted Manuscripts.
For
human research, the manuscript should include approval from the Institutional
Review Board (IRB). In research utilizing
human-derived materials, authors must explicitly state that written informed
consent was obtained from all participants prior to inclusion in the study. All
procedures involving the use of experimental animals must adhere to the ethical
guidelines established by the Institutional Animal Care and Use Committee
(IACUC). Authors must indicate that the study protocol was approved by the
IACUC (or an equivalent institutional ethics committee), or that all animal
procedures conformed to the ethical standards of the institution and complied
with the NIH Guide for the Care and Use of Laboratory Animals (http://www.nap.edu/read/5140/chapter/1).
In addition, all
manuscripts submitted to this journal must comply with the guidelines
recommended by the Gender Innovation Policy (http://gister.re.kr/gis/kr/gender/gender02.php). Authors
should distinguish between sex (biological factors) and gender (identity,
psychosocial, or cultural factors) when presenting research findings. Ideally,
studies should include both male and female participants and perform a
comparative analysis of the results. In cases where only one sex is studied,
authors are encouraged to provide a rational explanation. The manuscript should
also distinguish between race and ethnicity and describe the methods used to
determine these categories and their relevance.
2) Guidelines on the
Use of Artificial Intelligence (AI)
Archives of Obesity and
Metabolism adheres to the guidelines of the International Committee of Medical
Journal Editors (ICMJE) and encourages transparent disclosure and responsible
use of artificial intelligence (AI) technologies during manuscript preparation.
Generative AI tools may be used in a limited capacity to enhance linguistic clarity, such as grammar correction, vocabulary refinement, and improvement of readability. However, AI must not be used to generate scientific content, interpret data, or draw key research conclusions. If AI tools are used to generate content, create images, write code, process data, or perform translations, such usage must be clearly disclosed at the time of submission. Authors are required to specify the purpose and extent of AI use as outlined below.
(1)
Authorship
AI tools
(e.g., chatbots) cannot be credited as authors and must not be listed as
co-authors.
(2)
Plagiarism and Accountability
All
analyses, interpretations, and conclusions must be the intellectual work of the
authors. The use of AI-generated text or images that constitutes plagiarism is
strictly prohibited. Authors must be aware of the risks associated with
inappropriate AI use, including unintentional plagiarism, factual inaccuracies,
and hallucinations, and are strongly encouraged to conduct plagiarism and
similarity checks prior to submission.
(3)
Citation of AI-Generated Content
Content
generated by AI cannot be cited as a primary source.
(4)
Disclosure of AI Use
If AI tools
are used in manuscript preparation, the tool’s name, version, and purpose of
use must be clearly disclosed in a dedicated section titled "Declaration
of Generative AI and AI-Based Tool Use", placed immediately before the
References section. Authors may use the following template:
Declaration of Generative AI and
AI-Based Tool Use
"During
the preparation of this manuscript, the authors used [Tool Name] (version
[Version]) to assist with [e.g., grammar correction, vocabulary enhancement, or
readability improvement]. The authors have thoroughly reviewed the content
generated by the AI tool and take full responsibility for the final version of
the manuscript."
① Cover page (including ORCID), ② English
abstract and keywords, ③ Main body
(Introduction, Methods, Results, Conclusion), ④ Conflicts of
interest, ⑤ Funding sources, ⑥ Acknowledgments
(if applicable,),
⑦ References, ⑧ Tables (if applicable,), ⑨ Figures and figure legends (if applicable,), ⑩ Appendices (if applicable,)
The
manuscript length, excluding the cover page, references, English abstract,
tables, figures, and figure legends, should not exceed 10,000 words (including
spaces). The total number of tables and figures (including photographs) should
not exceed 10 and the number of references should be limited to 100.
① Cover Page
The cover page should include the title of the manuscript, running title, and names and affiliations of all authors in both Korean and English. When there are two or more authors, they should be listed in the order of their contributions to the research and manuscript writing, separated by commas. In English, the authors' names should follow the format of first name followed by last name, with the first letter of each syllable capitalized if the name is split. If the authors have different affiliations, Arabic numerals in superscript should be placed after the authors' names and before the institutional names to match the order of authorship. The corresponding author, responsible for revising the manuscript, should have their name, English affiliation, address, phone number, and email address listed on the cover page. Additionally, the word count of the manuscript (excluding the abstract, acknowledgments, references, and figure/table captions), the word count of the English abstract, and the number of tables and figures should be provided. Finally, all authors should include their Open Researcher and Contributor ID (ORCID) (e.g., Gil-Dong Hong, http://orcid.org/0000-0003-1234-5678). Authors who do not have an ORCID should register at http://orcid.org and include the ID.
② English Abstract and Keywords
The
English abstract should be written in an unstructured format and not exceed 250
words. The abstract should provide a concise summary of the entire manuscript,
including the main content in a manner that is easy to understand. At the
bottom of the abstract, four to six keywords should be provided. It is
recommended that the keywords be selected from the vocabulary listed in the
Medical Subject Headings (MeSH) by the U.S. National Library of Medicine.
③ Main Body
The main body of the
manuscript should be written in the following order: Introduction, Main Text,
and Conclusion. The main text can be subdivided into several sections based on
the content.
※Author names and affiliations should not be included in the main body of the manuscript.
④ Conflicts of
Interest
When submitting a
manuscript, all relevant matters related to consultancy fees or any other
financial or personal interests that may create a conflict of interest should
be disclosed. Examples of conflicts of interest include research funding from
pharmaceutical companies and political pressure from interest groups. If there
are no conflicts of interest, the following statement should be included:
"The authors declare no conflicts of interest."
⑤ Funding
Any
funding received for the research must be clearly stated. If no funding was
received, the statement "No funding" should be included.
⑥ Acknowledgments (If Applicable)
If necessary,
individuals who contributed to the manuscript but did not meet the authorship
criteria may be acknowledged in the Acknowledgments section. The specific roles
of the contributors in the research must be clearly stated. The authors must
inform and obtain consent from the individuals listed in Acknowledgments.
⑦ References
References should be
written in English, and the number of references for reviews is limited to 100.
The references should be listed in the order in which they are cited in the
text, with Arabic numerals and double spacing. If there are six or fewer authors,
all should be listed; if there are seven or more, the first three authors
should be listed followed by "et al." References in Korean should be
written in English as indicated in the reference itself. It is recommended that
reference management software be used when preparing references.
For journal names,
refer to the National Library of Medicine’s list (https://www.ncbi.nlm.nih.gov/books/NBK7256/) for
English journals and the Korean Medical Journal Information (http://journals.koreamed.org) for Korean
journals.
Abstracts are generally
not acceptable as references; however, if unavoidable, it should be clarified
that only the abstract is being cited. If citing an article that has been
accepted but not yet published, it should be noted as "Online ahead of
print" in square brackets.
In the main text, the
reference number should be indicated in superscript following the relevant
content. When citing three or more consecutive references, the range should be
indicated with a hyphen between the first and last numbers. The superscript
reference number should appear after the author's name when cited and after the
last word of the content if there is no author. Particles should appear after
the superscript, and commas and periods should precede the superscript. When
there are more than three authors, "et al." is used, and the
superscript follows after "et al."
A. Journal articles: Author(s), title, journal
name, publication year; volume, start page–end page
-
If there are six or fewer authors
Seo HK, Ji SH, Jhun HJ. Smoking prevalence and habits of
physicians in Korea: a mail questionnaire survey conducted in 2000. J Korean
Acad Fam Med 2007; 28: 599-603.
-
If there are seven or more authors
Rose ME, Huerbin MB, Melick J, et al. Regulation of
interstitial excitatory amino acid concentrations after cortical contusion
injury. Brain Res. 2002;935(1-2):40-6.
-
If the author is an organization
Diabetes Prevention Program Research Group. Hypertension,
insulin, and proinsulin in participants with impaired glucose tolerance. Hypertension.
2002;40(5):679-86.
If published online
ahead of print
Guan WJ, Ni ZY, Hu Y, et al. Clinical
characteristics of coronavirus disease 2019 in China N Engl J Med
February 28, 2020 [Online ahead of print]
https://www.nejm.org/doi/full/10.1056/NEJMoa2002032. 10.1056/NEJMoa2002032.
B. Books: Author's name, Book title, Edition, Place
of publication, Publisher, Year of publication (if applicable, start page–end
page).
If
the author is an individual
Vander Vorst A, Rosen A, Kotsuka Y. RF/Microwave
Interaction with Biological Tissues. Hoboken, NJ: John Wiley & Sons,
Inc.; 2005.
-
If it is an edited book
Chen JZM. Canadian-Daoist Poetics, Ethics, and
Aesthetics: An Interdisciplinary and Cross-cultural Study. 1st ed. 2015.
Berlin, Heidelberg: Springer; 2016.
-
When
using a chapter from an edited book
Tan L. A Residual Energy-Based Fairness Scheduling MAC
Protocol for Wireless Sensor Networks. In: Gao H, Lim L, Wang W, Li C, Chen L,
editors. Web-Age Information Management: 13th International Conference,
WAIM 2012, Harbin, China, August 18-20, 2012. Proceedings. Berlin, Heidelberg:
Springer; 2012. p. 35–46.
C. Conference Proceedings: Author's name, Title,
Name of the conference proceedings (if no specific title, use the conference
name), Date of the conference (year, month, day), Location of the conference,
Place of publication, Publisher, Year of publication.
Kimura J, Shibasaki H, editors. Recent advances in
clinical neurophysiology. Proceedings of the 10th International Congress of
EEMG and Clinical Neurophysiology; 1995 Oct 15-19; Kyoto, Japan. Amsterdam:
Elsevier; 1996.
D. Thesis or
Dissertation: Author's name, Title of the thesis
[dissertation], City of the awarding university, Name of the awarding
university, Year, Language. (Note: The language is not included if it is
English.)
Song YM. The Relationship between low serum cholesterol
level and cancer mortality [dissertation]. Seoul: Seoul National Univ.; 1997.
Korean.
Kaplan SJ. Post-hospital home health care: the elderly's
access and utilization [dissertation]. St. Louis (MO): Washington Univ.; 1995.
E. Public Institution
Documents: Name of the institution, Title, Location of the
institution, Publisher, Year.
Government Accountability Office. Highlights of a Forum:
Data and Analytics Innovation: Emerging Opportunities and Challenges.
Washington, DC: U.S. Government Printing Office; 2016.
F. Web Page: Author,
Title, Date of citation and last update, URL.
Luntz S. Almost A Third Of New FDA-Approved
Pharmaceuticals Have Post-Trial Safety Events [Internet]. IFLScience. 2017
[cited 2018 Oct 30]; Available from: https://www.iflscience.com/health-and-medicine/almost-a-third-of-new-fda-approved-pharmaceuticals-have-post-trial-safety-events/
The title of the table
should be aligned at the top left. The tables should be numbered in the order
they are cited in the text. The word “Table(표)”
should be followed by one space, the Arabic numeral, and a period. The title
should not end with a period. In the main text, refer to the table as “(Table
number).”
Tables should be
created with double spacing and placed on separate pages. Except for the top
horizontal line, no other horizontal or vertical lines should be used inside
the table. If abbreviations are used in the table or if any explanation is
needed, the footnotes should be provided at the bottom of the table. Use
lowercase letters (a, b, c) as superscripts on the right side of the part
needing an explanation and align the corresponding footnotes at the bottom.
Units used in the table
should be indicated within the table itself and should not be separately noted
outside the table. Avoid using unnecessary capital letters for unit symbols.
When creating tables, include information such as the average, standard
deviation, and sample size. In the footnotes, specify the statistical methods
used. For ratios, provide both the response count and the ratio, and for
correlation coefficients, provide the correlation coefficient value.
Figures
or photos should be submitted as separate files in PDF, GIF, Tagged Image File
Format (TIF or TIFF), or Adobe Illustrator (.ai) formats at a resolution of 600
dpi or higher. When creating figures, use bar graphs or line graphs to represent
averages or proportions, and indicate the size of the standard deviation or
standard error. The p-value must always be presented. Specify the statistical
methods used in the figure caption. The title should end with a period.
Figures
should be numbered in the order they are cited in the main text, following the
word “Figure” with a single space and using Arabic numerals with a period after
the number. In the main text, refer to the figure as “(Figure number).” If
there are multiple images under one figure number, label them as “그림 1가,”
“그림 2나,”
and so on.
⑩ Supplementary Appendix (If Applicable)
The appendix
of the manuscript must be paginated along with the table of contents and should
include the list of researchers (if applicable), text (e.g., methods), figures,
tables, and references. The references cited in the reference list should be
included separately in the appendix. It must be submitted as a separate MS Word
file and will be published unedited as additional information provided by the
author.
(2) Original article
① Title page
(including ORCID), ② English
abstract (Abstract) and Keywords, ③ Main body
(Introduction, Methods, Results, Discussion), ④ Conflicts
of Interest, ⑤ Funding, ⑥
Acknowledgments (if applicable), ⑦ References,
⑧ Tables (if
applicable), ⑨ Figures and Figure
Captions (if applicable), ⑩ Appendix
(if applicable) should be arranged in consecutive order.
The length of the
manuscript, excluding the title page, English abstract, references, tables,
figures, and figure captions, should not exceed 10,000 words (including
spaces). The total number of tables and figures or photos combined should not
exceed 10. The number of references should be limited to 40. The manuscript
should generally follow the submission guidelines for reviews: CONSORT (http://www.consort-statement.org) for
randomized controlled trials, STROBE (http://www.strobe-statement.org) for
observational studies, PRISMA (http://www.prisma-statement.org) for
systematic reviews and meta-analyses, and STARD (http://www.stard-statement.org) for
studies on diagnostic accuracy. The main text should be written as follows:
The English abstract
should be within 250 words and follow the format of Background, Methods,
Results, and Conclusion. The abstract should summarize the entire paper in a
concise and easy-to-understand manner. Below the abstract, 4 to 6 keywords
should be listed, using terms from the MeSH as recommended by the U.S. National
Library of Medicine.
-Introduction: Describe
the purpose of the paper and explain why it is important. Summarize the
background and principles of the research and limit the references to those
directly related.
-Methods: Provide a
detailed and specific description of the research plan, subjects, and methods.
Clearly define the research subjects and describe statistical methods in detail
to allow the results in the paper to be verified and reproduced. For research
involving human subjects, indicate that approval was obtained from the IRB.
When mentioning equipment or reagents, include the name, manufacturing company,
city, and country of the company in parentheses. If new or modified methods are
used, briefly introduce them along with references. Quantify the research
results and report measurement errors or uncertainties (e.g. confidence
intervals) and present the p-value. Specify the statistical software used for
analysis.
-Results: Present the
research results clearly and logically. Use tables and figures consistent with
the main body and summarize key points and trends in the text.
-Discussion: Emphasize
new and important findings from the methods and results and provide conclusions
based on these findings. Interpret the results in relation to other data,
avoiding repetition of the results. Discuss the implications of the results,
limitations in interpretation, and potential applications in future research. Compare
the results with other studies, linking the conclusion to the research
objectives. Propose new hypotheses based on the results and suggest appropriate
ways to verify them.
(3) Case report
① Title page
(including ORCID), ② English
abstract (Abstract) and Keywords, ③ Main body
(Introduction, Case Report, Discussion), ④ Conflicts
of Interest, ⑤ Funding, ⑥
Acknowledgments (if applicable), ⑦ References,
⑧ Tables (if
applicable), ⑨ Figures and Figure
Captions (if applicable), ⑩ Appendix
(if applicable) should be arranged in consecutive order.
The
English abstract for the case report should be written in an unstructured format and
be no longer than 250 words. The abstract should summarize the entire content
of the paper in a clear and easy-to-understand manner.
The
manuscript length, excluding the title page, references, tables, figures, and
figure captions, should not exceed 2,500 words (including spaces). The number
of keywords should be between 4 and 6, and terms from the U.S. National Library
of Medicine's MeSH
are recommended. The number of references should be limited to 20. The total
number of tables, figures, or photos combined should not exceed 10.
※ Author information, including the author's
name and affiliation, should only be included on the title page and not in the
main body.
(4) Perspective
① Title page
(including ORCID), ② English
abstract (Abstract) and Keywords, ③ Main body, ④ Conflicts
of Interest, ⑤ Funding, ⑥
Acknowledgments (if applicable), ⑦ References,
⑧ Tables (if
applicable), ⑨ Figures and Figure
Captions (if applicable), ⑩ Appendix
(if applicable) should be arranged in consecutive order.
The
English abstract
and manuscript for the case report should be written in an unstructured format. The
abstract should be no longer than 250 words and must summarize the entire
content of the paper in a clear and easy-to-understand manner.
The
manuscript length, excluding the title page, references, tables, figures, and
figure captions, should not exceed 1,500
words (including spaces). The number of keywords should be
between 4 and 6, and terms from the U.S. National Library of Medicine's MeSH are recommended.
The number of references should be limited to 20. The total number of tables,
figures, or photos combined should not exceed 3.
※ Author information, including the author's
name and affiliation, should only be included on the title page and not in the
main body.
(5) Editorial
① Title page
(including ORCID), ② Main body, ③ Conflicts
of Interest, ④ References, ⑤ Tables (if
applicable), ⑥ Figures and Figure
Captions (if applicable), ⑦ Appendix
(if applicable) should be arranged in consecutive order.
The manuscript
should be written in an unstructured
format and should not exceed 750 words (including spaces) excluding the
title page, references, tables, figures, and figure captions. The number of
references was limited to 10. The total number of tables, figures, or photos
combined should not exceed 1.
※ Author
information, including the author's name and affiliation, should only be
included on the title page and not in the main body.
(6) Correspondence
① Title page
(including ORCID), ② Main body, ③ Conflicts
of Interest, ④ Funding, ⑤
Acknowledgments (if applicable), ⑥ References,
⑦ Tables (if
applicable), ⑧ Figures and Figure
Captions (if applicable), ⑨ Appendix
(if applicable) should be arranged in consecutive order.
The
manuscript should be written in an unstructured
format, and the length must not exceed 400 words (including
spaces), excluding the title page, references, tables, figures, and figure
captions. The number of references should be limited to 10. The total number of
tables, figures, or photos combined should not exceed 1.
※ Author information, including the author's name and affiliation, should only be included on the title page and not in the main body.
3.
Submission of Manuscripts
All manuscript submissions must be made through the online submission system of the Society for Korean Obesity and Metabolism Studies (ACOMS+ Obesity and Metabolism Journal) available at accesson.kr. All subsequent review and editorial processes will also be conducted through this system. The progress of the manuscript review, along with related inquiries and responses, can be checked at any time through the online submission system. Prior to submitting a manuscript, authors must review the "Author’s Guide" available in the online submission system.
4.
Manuscript Review and Acceptance
All submitted manuscripts will be reviewed by at least two experts in the relevant field, and the decision on manuscript acceptance will be based on the results of the review. If the review results differ, the manuscript will be subject to re-evaluation by the Editorial Board before the final acceptance decision is made. If the Editorial Board requests revisions to the manuscript based on the expert review, the author must make the revisions within 4 weeks in accordance with the review comments and submit the revised manuscript along with a detailed list of the revisions as a 'Response to the Author' through the online submission system. If the author does not submit the revised manuscript within 12 weeks after receiving revision recommendations, the manuscript will be considered abandoned for publication. The final decision regarding the acceptance of the manuscript will be made by the Editorial Board after the expert review process. Additionally, the Editorial Board may recommend revisions or withhold publication for manuscripts that do not comply with the guidelines.
5.
Publication Decision
Once the decision to
publish the manuscript has been made, the author will receive a PDF version of
the manuscript file. The author must review the file within 2 days to check for
any errors, such as typos or other issues, and request corrections if
necessary. If a significant error that violates the submission guidelines is
discovered after the publication decision, the Editorial Board will request
revisions from the author. Publication may be delayed until the necessary
corrections are completed.
Attachments | |
---|---|
aom_(1).ens | |
투고가이드_개정_20250420.docx |